NCT06092047
- Conditions
- CD19-positive Relapsed or Refractory B-cell Malignancies
- Locations
-
- The First Affiliated Hospital of USTC (AnHui Provincial Hospital) Hefei, Anhui, China
Clinical trial condition
CD19-positive Relapsed or Refractory B-cell Malignancies
Explore clinical trials studying CD19-positive Relapsed or Refractory B-cell Malignancies. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study